Article
Variations within hepatitis C virus E2 protein and response to interferon treatment.
Virus research - 1 Jun 2001
Lo S, Lin H H
Abstract excerpt
To determine whether the hepatitis C virus (HCV) E2 PePHD sequence (aa 659-670; PKR-eIF2alpha phosphorylation homology domain) is the determinant for the response of interferon treatment, we have analyzed PePHD sequences in HCV-infected patients who had received interferon-alfa treatment. The PePHD sequence from all (6/6) of the patients, who are non- or partial responders to the interferon treatment, is the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
